Kim Warren

Lonza Walkersville, Inc. develops, manufactures and provides testing services for cell-based therapeutics. Its services include life-science customers, research organizations, pharmaceutical, biopharmaceutical, biotechnology and generic drug companies. The company was founded was founded on May 9, 1991 and is headquartered in Walkersville, MD.

Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada.

Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ.

Part of Cambrex Corp., Poietic Technologies, Inc. supplies normal human cells of hematopoietic origin. The company is based in Gaithersburg, MD. The company was founded by Kim Warren. Poietic Technologies was acquired by Cambrex Corp. on December 28, 1998 for $2.50 million.

Horizon Education LLC builds sustainable SAT/ACT programs for schools and organizations. The company is based in Laguna Beach, CA. The company provides professional development, personalized curriculum, and assessments for teachers and students. The company was founded in 2013 by Dustin Bainbridge and Michelle Sauceda. Dustin Bainbridge has been the CEO since 2013. Horizon Education was acquired by Progress Learning LLC on June 23, 2022.

ImmuneBridge, Inc. is a biotech company that is developing the next generation of allogeneic cellular medicines to make curative cancer therapies accessible to everyone. The company is based in San Francisco, CA and was founded in 2018 by Jesse Cotari and Peretz Partensky. The company is starting with NK cell-based immunotherapies. The company's proprietary expansion technology amplifies cord blood-derived immune stem cells while maintaining full immune multipotency to create a consistent and abundant cellular source for immunotherapies. ImmuneBridge's scientific approach harnesses this expansion technology along with the unique benefits of umbilical cord blood to enable robust screening and selection for the most potent cancer-fighting cells. Peretz Partensky has been the CEO since 2018.